Securities Code: 301507
Securities Abbreviation: Minsheng Health
Announcement No.: 2026-033
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Announcement on Progress of Second Phase Share Repurchase by Centralized Bidding
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.
Key Information Prompt:
● Progress of the second phase repurchase plan: As of July 31, 2026, Hangzhou Minsheng Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has cumulatively repurchased 2,320,000 shares through a dedicated securities account for repurchases, via centralized bidding, accounting for 0.65% of the Company's total share capital. The highest transaction price was RMB 15.67 per share, the lowest transaction price was RMB 11.77 per share, and the payment amount was RMB 34,152,462 (excluding transaction fees).
I. Basic Information on Share Repurchase